64
Views
0
CrossRef citations to date
0
Altmetric
Research

Evaluation of pharmacy-led weight management service to minimise the risk of cardiovascular disease

&
Article: 54 | Received 17 Mar 2021, Accepted 18 Jun 2021, Published online: 04 Dec 2023

References

  • Vidal J. Updated review on the benefits of weight loss. Int J Obes. 2002;26(S4):S25–S28.
  • MacMahon S, Cutler J, Brittain E, Higgins M. Obesity and hypertension: epidemiological and clinical issues. Eur Heart J. 1987. https://doi.org/10.1093/eurheartj/8.suppl_B.57.
  • Dattilo AM, Kris-Etherton PM. Effects of weight reduction on blood lipids and lipoproteins: a meta-analysis. Am J Clin Nutr. 1992;56(2):320–328.
  • Martínez-González MA, García-Arellano A, Toledo E, Salas-Salvadó J, Buil-Cosiales P, Corella D, et al. A 14-item Mediterranean diet assessment tool and obesity indexes among high-risk subjects: the PREDIMED trial. PLoS ONE. 2012;7:8 e43134.
  • Browning LM, Hsieh SD, Ashwell M. A systematic review of waist-to-height ratio as a screening tool for the prediction of cardiovascular disease and diabetes: 0·5 could be a suitable global boundary value. Nutr Res Rev. 2010;23(02):247–269.
  • Schröder H, Fitó M, Estruch R, Martínez-González MA, Corella D, Salas-Salvadó J, et al. A short screener is valid for assessing Mediterranean diet adherence among older spanish men and women. J Nutr. 2011;141(6):1140–1145.
  • Ashwell M, Cole TJ, Dixon AK. Ratio of waist circumference to height is strong predictor of intra-abdominal fat. BMJ. 1996;313(7056):559–560.
  • Roriz AKC, Passos LCS, de Oliveira CC, Eickemberg M, de Moreira PA, Sampaio LR. Evaluation of the accuracy of anthropometric clinical indicators of visceral fat in adults and elderly, Atkin SL editor. PLoS ONE. 2014;9(7):e103499.
  • Ashwell M, Gibson S. Waist-to-height ratio as an indicator of “early health risk”: simpler and more predictive than using a “matrix” based on BMI and waist circumference. BMJ Open. 2016;6(3):e010159.
  • Piepoli MF, Hoes AW, Agewall S, Albus C, Brotons C, Catapano AL, et al. 2016 European Guidelines on cardiovascular disease prevention in clinical practice. Eur Heart J. 2016;37(29):2315–2381.
  • Jennings CS, Graham I, Gielen S. The ESC Handbook of preventive cardiology putting prevention into practice. First. Oxford: Oxford University Press; 2016.
  • Cavaliere A, De Marchi E, Banterle A. Exploring the adherence to the mediterranean diet and its relationship with individual lifestyle: the role of healthy behaviors, pro-environmental behaviors, income, and education. Nutrients. 2018;10(2):141.
  • Eguaras S, Toledo E, Hernández-Hernández A, Cervantes S, Martínez-González MA. Better Adherence to the Mediterranean Diet Could Mitigate the Adverse Consequences of Obesity on Cardiovascular Disease: The SUN Prospective Cohort. www.mdpi.com/journal/nutrients. Accessed 14 Oct 2018.
  • Tong TYN, Wareham NJ, Khaw K-T, Imamura F, Forouhi NG. Prospective association of the Mediterranean diet with cardiovascular disease incidence and mortality and its population impact in a non-Mediterranean population: the EPIC-Norfolk study. BMC Med. 2016;14(1):135.
  • Panagiotakos DB, Georgousopoulou EN, Pitsavos C, Chrysohoou C, Metaxa V, Georgiopoulos GA, et al. Ten-year (2002–2012) cardiovascular disease incidence and all-cause mortality, in urban Greek population: The ATTICA Study. Int J Cardiol. 2015. https://doi.org/10.1016/j.ijcard.2014.11.206.
  • Martínez-González MÁ, Ruiz-Canela M, Hruby A, Liang L, Trichopoulou A, Hu FB. Intervention trials with the mediterranean diet in cardiovascular prevention: understanding potential mechanisms through metabolomic profiling. J Nutr. 2015;146(4):913S–919S.
  • Sofi F, Cesari F, Abbate R, Gensini GF, Casini A. Adherence to Mediterranean diet and health status: meta-analysis. BMJ. 2008;337(7671):673–675
  • Simopoulos AP. The Mediterranean diets: what is so special about the diet of Greece?. The Scientific Evidence J Nutr. 2001;131(11):3065S–3073S.
  • Martinez-Gonzalez MA, Martín-Calvo N. Mediterranean diet and life expectancy; beyond olive oil, fruits and vegetables HHS Public Access. Curr Opin Clin Nutr Metab Care. 2016;19(6):401–407.
  • Schulze MB, Hoffmann K. Methodological approaches to study dietary patterns in relation to risk of coronary heart disease and stroke. Br J Nutr. 2018. https://doi.org/10.1079/BJN20061731.
  • My CMS | National Study of Morbidity and Risk Factors. http://emeno.gr/. Accessed 30 Jul 2018.
  • Pharmacy Services in Europe: Evaluating Trends and Value. Executive Summary. Lisbon: Institute for Evidence-Based Health (ISBE);2020. https://www.pgeu.eu/wp-content/uploads/2021/02/ISBE-EXECUTIVE-SUMMARY_Pharmacy-Services-in-Europe_Evaluating-Trends-and-Value_-20210205.pdf.
  • Peletidi A, Nabhani-Gebara S, Kayyali R. The role of pharmacists in cardiovascular disease prevention: qualitative studies from the United Kingdom and Greece. J Res Pharm Pract. 2019;8(3):112.
  • Peletidi A, Kayyali R. Experiences of the pharmacy-led weight management service: views of service providers in England. Pharmacy. 2019;7(3):82.
  • Hussain R, Hassali Azmi M, Babar Ud-Din Z. Qualitative methods in pharmacy practice research. Encycl Pharm Pract Clin Pharm. 2019. https://doi.org/10.1016/B978-0-12-812735-3.00603-8.
  • Ramzan S, Hadi MA, Babar ZUD. Mixed methods research in pharmacy practice: Basics and beyond. Encycl Pharm Pract Clin Pharm. 2019;21:46–52.
  • Tashakkori A, Creswell JW. Editorial: the new era of mixed methods. J Mix Methods Res. 2007;1(1):3–7. https://doi.org/10.1177/2345678906293042.
  • Weigh-2-Go. http://www.kingstonccg.nhs.uk/stay-healthy/weigh-2-go.htm/. Accessed 13 Aug 2018.
  • Aguiar EJ, Morgan PJ, Collins CE, Plotnikoff RC, Young MD, Callister R. The PULSE (Prevention Using LifeStyle Education) trial protocol: a randomised controlled trial of a Type 2 Diabetes Prevention programme for men. Contemp Clin Trials. 2014;39(1):132–144.
  • Morgan PJ, Callister R, Collins CE, Plotnikoff RC, Young MD, Berry N, et al. The SHED-IT community trial: a randomized controlled trial of internet- and paper-based weight loss programs tailored for overweight and obese men. Ann Behav Med. 2013;45(2):139–152.
  • Rosner B. Fundamentals of biostatistics. 4th ed.California: Duxbury Press; 1995. p. 221.
  • Sample size for before-after study (Paired T-test) | Sample Size Calculators. http://www.sample-size.net/sample-size-study-paired-t-test/. Accessed 20 Aug 2018.
  • Traversy G, Chaput J-P. Alcohol consumption and obesity: an update. Curr Obes Rep. 2015;4:122–130.
  • Agnoli C, Sieri S, Ricceri F, Giraudo MT, Masala G, Assedi M, et al. Nutrition & Diabetes Adherence to a Mediterranean diet and long-term changes in weight and waist circumference in the EPIC-Italy cohort. Nutr Diabetes. 2018;8:22.
  • Winter H. Waist management: a pilot scheme using community pharmacists to address the issue of obesity. Pharm Manag. 2007;23(2):14–18
  • Bescoby S, Millar D. Obesity management in a community pharmacy setting-a pilot study. Int J Pharm Pract. 2006;14(Supplement 2):B117–B118
  • Boardman HF, Avery AJ. Effectiveness of a community pharmacy weight management programme. Int J Clin Pharm. 2014. 36(4):800–806.
  • Data Protection Act 1998. https://www.legislation.gov.uk/ukpga/1998/29/contents. Accessed 20 Aug 2018.
  • The Common Law Duty of Confidentiality | Department of Health. https://www.health-ni.gov.uk/articles/common-law-duty-confidentiality. Accessed 20 Aug 2018.
  • National Clinical Guideline Centre (UK). Obesity: identification, assessment and management management. London: National Institute for Health and Care Excellence; 2014.
  • Weidmann AE, MacLure K, Marshall S, Gray G, Stewart D. Promoting weight management services in community pharmacy: perspectives of the pharmacy team in Scotland. Int J Clin Pharm. 2015;37(4):599–606.
  • Bush J, Langley C, Mills S, Hindle L. A comparison of the provision of the My Choice Weight Management Programme via general practitioner practices and community pharmacies in the United Kingdom. Clin Obes. 2014;4(2):91–100. https://doi.org/10.1111/cob.12049
  • Bush J, Langley C, Patel A, Harvey J. Evaluation of the Heart of Birmingham teaching Primary Care Trust (HoBtPCT): My Choice Weight Management Programme: report commissioned by Heart of Birmingham teaching Primary Care Trust. 2011. https://research.aston.ac.uk/portal/en/researchoutput/evaluation-of-the-heart-of-birmingham-teaching-primary-care-trust-hobtpct-my-choice-weight-management-programme(b7aea05e-c9ff-4902-b7bc-40f1107fbc62).html. Accessed 16 Jul 2018.
  • Poobalan AS, Aucott LS, Smith WCS, Avenell A, Jung R, Broom J. Long-term weight loss effects on all cause mortality in overweight/obese populations. Obes Rev. 2007;8(6):503–513. https://doi.org/10.1111/j.1467-789X.2007.00393.x.
  • Hitchman SC, Fong GT. Gender empowerment and female-to-male smoking prevalence ratios. Bull World Health Organ. 2011;89(3):195–202.
  • Pistelli F, Aquilini F, Carrozzi L. Weight gain after smoking cessation. Monaldi Arch Chest Dis. 2016;71(2):81–87.
  • Morrison D, McLoone P, Brosnahan N, McCombie L, Smith A, Gordon J. A community pharmacy weight management programme: an evaluation of effectiveness. BMC Public Health. 2013;13(1):1.
  • Harmon M, Pogge E, Boomershine V. Evaluation of a pharmacist-led, 6-month weight loss program in obese patients. J Am Pharm Assoc. 2014;54(3):302–307. https://doi.org/10.1331/JAPhA.2014.13138.
  • MacMahon S, Peto R, Cutler J, Collins R, Sorlie P, Neaton J, et al. Blood pressure, stroke, and coronary heart disease. Part 1, Prolonged differences in blood pressure: prospective observational studies corrected for the regression dilution bias. Lancet. 1990;335(8692):765–774.
  • Aucott L, Rothnie H, McIntyre L, Thapa M, Waweru C, Gray D. Long-term weight loss from lifestyle intervention benefits blood pressure? A systematic review. Hypertension. 2009;54(4):756–762.
  • Chobanian AV, Bakris GL, Black HR, Cushman WC, Green LA, Izzo JL, et al. The Seventh report of the joint national committee on prevention, detection, evaluation, and treatment of high blood pressure:the JNC 7 report. JAMA. 2003;289(19):2560.
  • Swift DL, Johannsen NM, Lavie CJ, Earnest CP, Church TS. The role of exercise and physical activity in weight loss and maintenance. Prog Cardiovasc Dis. 2014;56(4):441–447.
  • Haskell WL, Lee I-M, Pate RR, Powell KE, Blair SN, Franklin BA, et al. Physical activity and public health: updated recommendation for adults from the American College of Sports Medicine and the American Heart Association. Med Sci Sports Exerc. 2007;39(8):1423–1434.
  • Kocla-Kimble MA, Batz FR. Diabetes care as an active learning model of postgraduate education and training for pharmaceutical care. Am J Pharm Educ. 1994;58:382–385
  • Nanchahal K, Power T, Holdsworth E, Hession M, Sorhaindo A, Griffiths U, et al. A pragmatic randomised controlled trial in primary care of the Camden Weight Loss (CAMWEL) programme. http://www.perfect-diet-tracker. Accessed 16 Aug 2018.
  • McConnon A, Kirk SF, Cockroft JE, Harvey EL, Greenwood DC, Thomas JD, et al. The Internet for weight control in an obese sample: results of a randomised controlled trial. BMC Health Serv Res. 2007;19(7):206.
  • Jolly K, Lewis A, Beach J, Denley J, Adab P, Deeks JJ, et al. Comparison of range of commercial or primary care led weight reduction programmes with minimal intervention control for weight loss in obesity: lighten Up randomised controlled trial. BMJ. 2011;343:d6500.
  • McCormick R, Bryant L, Sheridan J, Gonzalez J. New Zealand community pharmacist attitudes toward opioid-dependent clients. Drugs Educ Prev Policy. 2006;13(6):563–575.
  • Hattingh HL, Emmerton L, Ng Cheong Tin P, Green C. Utilization of community pharmacy space to enhance privacy: a qualitative study. Heal Expect. 2016;19(5):1098–1110.https://doi.org/10.1111/hex.12401
  • Weidmann AE, Cunningham S, Gray G, Hansford D, Bermano G, Stewart D. Views of the Scottish general public on community pharmacy weight management services: International implications. Int J Clin Pharm. 2012;34(2):389–397.